Published in Cardiology on August 04, 2011
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA (2006) 5.79
Arrhythmogenic right ventricular cardiomyopathy. Lancet (2009) 4.46
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail (2009) 3.54
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation (2006) 3.44
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest (2006) 3.22
Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med (2008) 3.19
Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet (2006) 2.26
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet (2009) 2.19
Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling. J Biol Chem (2002) 1.84
Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study. Circ Cardiovasc Genet (2009) 1.54
Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol (2006) 1.46
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace (2010) 1.40
Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol Genet Metab (2005) 1.22
Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15. Circulation (2004) 1.19
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med Genet (2007) 1.11
Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet (2008) 1.08
Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy. J Med Genet (2010) 1.02
Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations. Cardiovasc Res (2010) 0.92
Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clin Genet (2009) 0.90
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol (2007) 8.08
BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med (2008) 4.20
In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol (2010) 2.29
Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes (2007) 2.17
Hospital outcomes in major teaching, minor teaching, and nonteaching hospitals in New York state. Am J Med (2002) 2.16
Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Am J Med (2004) 2.15
Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One (2008) 1.99
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med (2007) 1.98
High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: fluoroscopic grading scale and correlation to extracted leads. Heart Rhythm (2012) 1.88
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood (2011) 1.63
Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet (2005) 1.61
Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signaling. ACS Chem Biol (2010) 1.51
Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2010) 1.51
Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest (2009) 1.48
Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol (2011) 1.43
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38
Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem (2007) 1.36
Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J Clin Invest (2005) 1.34
Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ Res (2003) 1.33
Biobanks and electronic medical records: enabling cost-effective research. Sci Transl Med (2014) 1.32
Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.23
Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol (2005) 1.20
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood (2011) 1.19
Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J (2006) 1.19
sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J Biol Chem (2010) 1.18
Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Am J Physiol Heart Circ Physiol (2005) 1.14
DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci (2012) 1.11
Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter. J Physiol (2007) 1.10
Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. J Immunol (2010) 1.08
The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.05
DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. PLoS One (2012) 1.04
Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One (2011) 0.99
Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. J Am Soc Nephrol (2010) 0.98
Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol (2012) 0.96
BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasion. Cell Signal (2012) 0.95
Long chain fatty acid uptake in vivo: comparison of [125I]-BMIPP and [3H]-bromopalmitate. Lipids (2008) 0.94
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm (2004) 0.93
Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Diabetes (2007) 0.93
Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One (2013) 0.93
Bone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion. PLoS One (2013) 0.93
Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. J Physiol (2005) 0.93
Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen. Cell Rep (2013) 0.92
Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes (2005) 0.90
Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett (2013) 0.89
BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model. Neurobiol Dis (2010) 0.89
Regenerative chemical biology: current challenges and future potential. Chem Biol (2011) 0.88
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol Dial Transplant (2013) 0.88
Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Circ Cardiovasc Genet (2013) 0.87
Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise. Am J Physiol Endocrinol Metab (2004) 0.87
Multi-step usage of in vivo models during rational drug design and discovery. Int J Mol Sci (2011) 0.87
Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States. Int J Cardiol (2005) 0.85
Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. Heart Rhythm (2009) 0.84
Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol (2013) 0.83
Conductor extrusion in a persistent left superior vena cava. Europace (2011) 0.83
Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine? Circulation (2013) 0.83
Large scale zebrafish-based in vivo small molecule screen. J Vis Exp (2010) 0.83
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record. Thromb Haemost (2014) 0.83
Application of small organic molecules reveals cooperative TGFβ and BMP regulation of mesothelial cell behaviors. ACS Chem Biol (2011) 0.82
Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience. J Cardiovasc Electrophysiol (2013) 0.82
Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease. Am J Cardiol (2003) 0.81
Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle. Biochim Biophys Acta (2008) 0.81
Mesenchymal stem cell transplantation for the infarcted heart: a role in minimizing abnormalities in cardiac-specific energy metabolism. Am J Physiol Endocrinol Metab (2011) 0.81
Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells. Anticancer Res (2014) 0.81
AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. Am J Physiol Endocrinol Metab (2004) 0.81
Familial dilated cardiomyopathy associated with congenital defects in the setting of a novel VCL mutation (Lys815Arg) in conjunction with a known MYPBC3 variant. Cardiogenetics (2011) 0.80
Modified mouse embryonic stem cell based assay for quantifying cardiogenic induction efficiency. J Vis Exp (2011) 0.80
Autotaxin signaling governs phenotypic heterogeneity in visceral and parietal mesothelia. PLoS One (2013) 0.80
Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy. Dis Model Mech (2012) 0.79
Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death. J Am Soc Hypertens (2010) 0.78
Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal stem cell therapy in the infarcted heart. Am J Physiol Cell Physiol (2013) 0.76
High content screening for modulators of cardiovascular or global developmental pathways in zebrafish. Methods Mol Biol (2015) 0.76
Serial observations and mutational analysis of an adoptee with family history of hypertrophic cardiomyopathy. Cardiol Res Pract (2010) 0.75
Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization. Arterioscler Thromb Vasc Biol (2012) 0.75
Stem cell therapy for chronic heart failure: an updated appraisal. Expert Opin Biol Ther (2013) 0.75
Recent Progress on Chemical Biology of Pluripotent Stem Cell Self-renewal, Reprogramming and Cardiomyogenesis. Recent Pat Regen Med (2011) 0.75
Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia. Ther Adv Cardiovasc Dis (2012) 0.75
Migration and infection of a pace-sense lead from an abdominal defibrillator system. Pacing Clin Electrophysiol (2002) 0.75
Preface. Chemical biology. Methods Mol Biol (2015) 0.75
Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection. J Cardiovasc Electrophysiol (2004) 0.75
Complete superior vena cava obstruction. J Am Coll Cardiol (2010) 0.75
Practical strategies for small-molecule probe development in chemical biology. Methods Mol Biol (2015) 0.75